Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

42.35
Delayed Data
As of Mar 24
 +0.63 / +1.51%
Today’s Change
41.38
Today|||52-Week Range
54.96
-13.50%
Year-to-Date

Today’s Trading

Previous close41.72
Today’s open41.77
Day’s range41.77 - 42.55
Volume123,614
Average volume (3 months)111,681
Market cap$620.0M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+6.97%
Earnings growth (this year)-6.82%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+11.16%
P/E ratio19.7
Price/Sales7.16
Price/Book2.78

Competitors

 Today’s
change
Today’s
% change
NVCRNovocure Ltd+0.15+2.17%
ANGOAngioDynamics Inc+0.05+0.30%
GNMKGenMark Diagnostics ...+0.26+1.98%
ATRCAtriCure Inc+0.36+1.94%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$103.4M
Annual profit (last year)$32.5M
Net profit margin31.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Dana M. Alexander
Corporate headquarters
Bedford, Massachusetts

Forecasts


Search for Jobs